Debasis Das

6PUBLICATIONS
0CO-AUTHORS
Biologically active moleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Major global burdens of diseaseMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 30, 2026
Design, synthesis, and biological evaluation of novel isobenzofuran-1(3H)-one derivatives with antioxidant properties and improved oral bioavailability.

|Jun 18, 2025
Discovery of Reversible, Noncovalent Bruton's Tyrosine Kinase Inhibitors Targeting BTK C481S Mutation.

Debasis Das, Lingzhi Xie, Dandan Qiao

|Mar 03, 2025
Signaling Pathways and Promising Small-Molecule Therapeutic Agents for Ischemic Stroke.

Debasis Das, Yimeng Wu, Jian Hong

|Sep 09, 2024
Next-generation EGFR tyrosine kinase inhibitors to overcome C797S mutation in non-small cell lung cancer (2019-2024).

Debasis Das, Lingzhi Xie, Jian Hong

|Jun 14, 2023
Discovery of Novel, Selective Prostaglandin EP4 Receptor Antagonists with Efficacy in Cancer Models.

Debasis Das, Dandan Qiao, Zhonghe Liu

|Apr 30, 2021
Next-Generation Kinase Inhibitors Targeting Specific Biomarkers in Non-Small Cell Lung Cancer (NSCLC): A Recent Overview.

Debasis Das, Jingbing Wang, Jian Hong

Pageof 1

Frequent Collaborators